Therapie der Clozapin-induzierten Hypersalivation mit Botulinum-Toxin B
Authors:
- 1 February 2005
- journal article
- kasuistiken
- Published by Springer Nature in Der Nervenarzt
- Vol. 76 (2) , 205-208
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Reduction Of Clozapine-Induced Hypersalivation By Pirenzepine Is SafePharmacopsychiatry, 2004
- The Effects of Clozapine Versus Haloperidol on Measures of Impulsive Aggression and Suicidality in Chronic Schizophrenia PatientsThe Journal of Clinical Psychiatry, 2003
- Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonismMovement Disorders, 2003
- Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disordersJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Use of atropine eye drops for clozapine induced hypersalivationAustralian & New Zealand Journal of Psychiatry, 2000
- Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Comparative Efficacy and Tolerability of Benzatropine and Terazosin in the Treatment of Hypersalivation Secondary to ClozapineClinical Drug Investigation, 1999
- Aspiration Pneumonia Possibly Secondary to Clozapine-Induced SialorrheaJournal of Clinical Psychopharmacology, 1996
- Clozapine-induced hypersalivation and the alpha2 adrenoceptorThe British Journal of Psychiatry, 1995
- Amitriptyline in clozapine-induced sialorrhoeaThe British Journal of Psychiatry, 1991